Stockscreener 앱 받기
142.73
1.30%
1.83
시장 영업 전:
142.73
Neurocrine Biosciences Inc 주식(NBIX)의 최신 뉴스
Neurocrine Biosciences CFO Matt Abernethy sells $115,908 in stock - MSN
Neurocrine Biosciences’ SWOT analysis: stock outlook amid pipeline progress, IRA challenges - Investing.com
Neurocrine Biosciences, Inc. $NBIX Shares Acquired by Voya Investment Management LLC - MarketBeat
Fed Watch: Why is Neurocrine Biosciences Inc stock going upJuly 2025 Highlights & Reliable Volume Spike Alerts - خودرو بانک
Woodline Partners LP Buys Shares of 132,892 Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine to present new phase 2 data for depression treatment - Investing.com India
Neurocrine Biosciences to Present New Data from Phase 2 Study of Osavampator in Adults with Major Depressive Disorder at 38th Annual Psych Congress 2025 - WV News
First-in-Class AMPA-PAM Depression Treatment: Neurocrine's Osavampator Phase 2 Results at Major Conference - Stock Titan
What Does Wall Street Think About Neurocrine Biosciences (NBIX)? - uk.finance.yahoo.com
Moving Averages: Is Neurocrine Biosciences Inc stock forming a triangle patternQuarterly Profit Review & Free High Accuracy Swing Entry Alerts - خودرو بانک
Juncture Wealth Strategies LLC Sells 2,766 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Volatility Watch: How cyclical is Neurocrine Biosciences Incs revenue streamWeekly Loss Report & Daily Risk Controlled Trade Plans - خودرو بانک
City Center Advisors LLC Buys New Stake in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
First Hawaiian Bank Trims Position in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Swedbank AB Has $47.52 Million Stock Holdings in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Performance Recap: What are Neurocrine Biosciences Incs growth leversWeekly Trade Analysis & Breakout Confirmation Trade Signals - خودرو بانک
Intech Investment Management LLC Has $3.96 Million Stake in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
United Services Automobile Association Buys Shares of 6,547 Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Integrated Wealth Concepts LLC Buys 4,526 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Plato Investment Management Ltd Has $255,000 Stock Holdings in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Teza Capital Management LLC Has $587,000 Stock Position in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Amundi Sells 30,673 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine Biosciences, Inc. $NBIX Shares Acquired by Jacobs Levy Equity Management Inc. - MarketBeat
Great Lakes Advisors LLC Has $3.54 Million Stock Position in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Vident Advisory LLC Invests $202,000 in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Short Interest Update - MarketBeat
Parkman Healthcare Partners LLC Buys 52,655 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Getting In Cheap On Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Might Be Difficult - 富途牛牛
Neurocrine Biosciences, Inc. $NBIX Shares Sold by Alyeska Investment Group L.P. - MarketBeat
EFG Asset Management North America Corp. Has $1.12 Million Stake in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Baird Financial Group Inc. Buys 3,103 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine at Morgan Stanley Conference: Strategic Growth and Innovation - Investing.com
Fibonacci Support Holding Strong in Neurocrine Biosciences Inc.July 2025 Trends & Weekly Chart Analysis and Guides - beatles.ru
Federation des caisses Desjardins du Quebec Lowers Stock Holdings in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Palo Alto Investors LP Invests $1.48 Million in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine Biosciences Inc. recovery potential after sell offJuly 2025 Momentum & Community Consensus Picks - Newser
Tick level data insight on Neurocrine Biosciences Inc. volatilityLong Setup & Entry Point Confirmation Signals - Newser
Neurocrine Biosciences, Inc. $NBIX Shares Sold by Trexquant Investment LP - MarketBeat
Is Neurocrine Biosciences Inc. benefiting from interest rate changesEarnings Overview Summary & Low Risk Entry Point Tips - خودرو بانک
Can Neurocrine Biosciences Inc. generate free cash flowJuly 2025 Closing Moves & Accurate Entry/Exit Alerts - خودرو بانک
Does Neurocrine Biosciences Inc. fit your quant trading modelJuly 2025 Macro Moves & Safe Entry Momentum Tips - Newser
Neurocrine Biosciences: RBC Capital maintains Outperform, raises PT to $149. - AInvest
Neurocrine Bio. stock price target raised to $149 by RBC Capital - Investing.com
RBC Raises Price Target on Neurocrine Biosciences to $149 From $144, Keeps Outperform Rating - MarketScreener
Armistice Capital LLC Acquires 108,190 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat
What’s next for Neurocrine Biosciences Inc. stock priceWeekly Profit Summary & Reliable Intraday Trade Alerts - Newser
Will Neurocrine Biosciences Inc. benefit from current market trendsMarket Growth Review & Weekly Consistent Profit Watchlists - خودرو بانک
Will Neurocrine Biosciences Inc. price bounce be sustainable2025 Key Lessons & Long-Term Capital Growth Strategies - Newser
Is Neurocrine Biosciences Inc. a cyclical or defensive stockJuly 2025 Breakouts & Weekly Return Optimization Alerts - خودرو بانک
Will Neurocrine Biosciences Inc. stock go up soonJuly 2025 Volume & Community Consensus Picks - Newser
Neurocrine at Cantor Global Healthcare Conference: Strategic Insights on Growth - Investing.com Canada
Neurocrine Biosciences Inc. stock retracement – recovery analysis2025 Stock Rankings & AI Forecasted Stock Moves - Newser
What are Neurocrine Biosciences Inc.’s growth leversPortfolio Gains Summary & AI Powered Buy and Sell Recommendations - خودرو بانک
CreativeOne Wealth LLC Buys 4,361 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat
0.88%
1.07%
자본화:
|
볼륨(24시간):